Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.
Krug LM, Miller VA, Kalemkerian GP, Kraut MJ, Ng KK, Heelan RT, Pizzo BA, Perez W, McClean N, Kris MG.
Krug LM, et al. Among authors: ng kk.
Ann Oncol. 2000 Feb;11(2):227-8. doi: 10.1023/a:1008349209956.
Ann Oncol. 2000.
PMID: 10761761
Free article.
Clinical Trial.
No abstract available.